Milrinone is a phosphodiesterase inhibitor, a cardiotonic drug with positive inotropic and vasodilating effects, which can be used to treat acute or chronic refractory congestive heart failure.
Millinone is a cardiotropic drug, belonging to phosphodiesterase inhibitors. By inhibiting phosphodiesterase, the drug can increase the concentration of cyclic adenosine phosphate and calcium in cardiomyocytes, thereby effectively strengthening myocardial contractility and increasing cardiac output, so as to exert positive muscle strength. In addition, Milrinone can also play a vasodilator role by directly acting on the small arteries.
milrinone supports ventricular functioning of the heart by decreasing the degradation of cAMP and thus increasing phosphorylation levels of many components in the heart that contribute to contractility and heart rate. Milrinone use following cardiac surgery has been under some debate because of the potential increase risk of postoperative atrial arrhythmias. However, in the short term milrinone has been deemed beneficial to those experiencing heart failure and an effective therapy to maintain heart function following cardiac surgeries. There is no evidence of any long term beneficial effects on survival.
Milrinone, is a medication used in patients who have heart failure. It is a phosphodiesterase 3 inhibitor that works to increase the heart's contractility and decrease pulmonary vascular resistance. Milrinone also works to vasodilate which helps alleviate increased pressures (afterload) on the heart, thus improving its pumping action. While it has been used in people with heart failure for many years, recent studies suggest that milrinone may exhibit some negative side effects that have caused some debate about its use clinically.
Overall, milrinone supports ventricular functioning of the heart by decreasing the degradation of cAMP and thus increasing phosphorylation levels of many components in the heart that contribute to contractility and heart rate. Milrinone use following cardiac surgery has been under some debate because of the potential increase risk of postoperative atrial arrhythmias. However, in the short term milrinone has been deemed beneficial to those experiencing heart failure and an effective therapy to maintain heart function following cardiac surgeries. There is no evidence of any long term beneficial effects on survival.
Wir haben viele hochwertige Fabriken mit enger Zusammenarbeit, die Ihnen qualitativ hochwertige Produkte und wettbewerbsfähige Preise bieten können. Außerdem können wir Rabatte für Großeinkäufe gewähren. Und wir arbeiten mit vielen professionellen Speditionen zusammen und können Ihnen Produkte sicher und reibungslos liefern. Die Lieferzeit beträgt ca. 3-20 Tage nach Zahlungsbestätigung.
Analyse
|
Spezifikation
|
Ergebnis
|
Test method
|
Physical Description
|
|
|
|
Aussehen
|
White Powder
|
White Powder |
Visual
|
Geruch
|
Characteristic
|
Characteristic
|
Organoleptic
|
Particle size
|
90% pass 80 mesh
|
90% pass 80 mesh
|
80 Mesh Screen
|
Chemical Tests
|
|
|
|
Assay (Lutein)
|
99%
|
90.15%
|
HPLC
|
Loss on drying
|
5.0% Max
|
1.82%
|
5g/105ºC/2hrs
|
Ash Contents
|
5.0% Max
|
1.12%
|
2g/525ºC/3hrs
|
Residual Solvents
|
50.0 ppm, Only Ethanol
|
<30.0 ppm
|
/
|
Heavy metals
|
5.0 ppm Max
|
<3.0 ppm
|
AAS
|
Lead
|
3.0 ppm Max
|
<1.0 ppm
|
AAS
|
Arsenic
|
3.0 ppm Max
|
<1.0 ppm
|
AAS
|
Microbiology Control
|
|
|
|
Total Bacteria Count
|
1,000cfu/g Max
|
<280cfu/g
|
AOAC
|
Yeast & Mold
|
100cfu/g Max
|
<10cfu/g
|
AOAC
|
Coliform
|
30.0 MPN/g Max
|
<3.0 MPN/g
|
AOAC
|
Abschluss
|
Complies with the standards.
|
||
General Status
|
Non-GMO, ISO Certificated.
|
Milrinone is a PDE3 (phosphodiesterase 3) inhibitor that exhibits vasodilator and positive inotropic effects. Milrinone's positive inotropic activity can be inhibited by carbachol (sc-202092). Research indicates that Milrinone can increase platelets and enhance cAMP levels. Milrinone is an inhibitor of PDE3A and PDE3B.
Milrinone, commonly known and marketed as the drug Primacor, is a medication used in patients suffering from heart failure. Milrinone is a phosphodiesterase 3 inhibitor that works to increase the heart's contractility. Milrinone also works to vasodilate vessels which helps alleviate increased pressures (afterload) on the heart, thus improving its pumping action. Milrinone has been used in those suffering from heart failure for many years.
1. Sind Sie eine Fabrik oder ein Handelsunternehmen?
Wir sind ein Unternehmen, das Industrie und Handel integriert und einen Service aus einer Hand bietet. OEM könnte akzeptiert werden.
2. Stellen Sie Muster zur Verfügung? Ist das kostenlos oder extra?
Kostenlose Proben. Die Frachtkosten für die Probe müssen von Ihnen bezahlt werden.
3. Besitzen Sie Zertifikate zur Qualitätskontrolle?
ISO 9001:2008-Zertifizierung zur Gewährleistung der Qualität.
4. Was muss ich angeben, um ein Angebot zu erhalten?
Bitte teilen Sie uns den Produkttyp mit, den Sie benötigen, die Bestellmenge, die Adresse und die spezifischen Anforderungen. Wir erstellen Ihnen rechtzeitig ein Angebot.
5. Welche Zahlungsmethode bevorzugen Sie? Welche Zahlungsbedingungen werden akzeptiert?
Akzeptierte Lieferbedingungen: FOB, CFR, CIF, EXW;
Akzeptierte Zahlungswährung: USD;
Akzeptierte Zahlungsarten: T/T, Western Union; Paypal, Trade Assurance.
Gesprochene Sprache: Englisch.
Produktkategorien